Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parecoxib or Ketorolac for Remifentanil-induced Hyperalgesia
NCT00785863Phase 4Completed
- Sponsor
- Ullevål University Hospital
- Start
- Dec 2008
- Primary completion
- Apr 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of parecoxib, ketorolac in hyperalgesia, sponsored by Ullevål University Hospital. Started Dec 2008; status: completed.
02
Drugs
parecoxibketorolac
03
Conditions
hyperalgesia
Beyond the preview
Go deeper on NCT00785863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00785863.